SCHEMBL2193972

SCHEMBL2193972

NCCCC[C@H](NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]([C]=O)CCC(=O)O

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 1/20 0.43
BACE1 P56817 9/20 0.39
CTSD P07339 3/20 0.39
DPP8 Q6V1X1 2/20 0.38
DPP9 Q86TI2 2/20 0.38
DPP4 P27487 1/20 0.38
DPP7 Q9UHL4 1/20 0.34
BMP1 P13497 1/20 0.34
NMT2 O60551 1/20 0.34
NMT1 P30419 1/20 0.34
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2A Q12879 1/20 0.34
GRIN2B Q13224 1/20 0.34
GRIN2C Q14957 1/20 0.34
GRIN3A Q8TCU5 1/20 0.34
SIRT5 Q9NXA8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1649812 0.94 FOLH1 (0.48) FOLH1DPP8DPP9DPP4DPP7
SCHEMBL2196575 0.93 FOLH1 (0.41) FOLH1BACE1CTSDDPP8DPP9
SCHEMBL2202327 0.92 FOLH1 (0.43) FOLH1BACE1CTSDDPP8DPP9
SCHEMBL2183342 0.90 FOLH1 (0.44) FOLH1BACE1CTSDDPP8DPP9
SCHEMBL31432569 0.87 FOLH1 (0.55) FOLH1BACE1CTSDDPP8DPP9
SCHEMBL8567236 0.85 FOLH1 (0.47) FOLH1DPP8DPP9DPP4DPP7
SCHEMBL1888867 0.85 FOLH1 (0.47) FOLH1DPP8DPP9DPP4DPP7
SCHEMBL1889778 0.85 DPP8 (0.47) FOLH1DPP8DPP9DPP4DPP7
SCHEMBL2194678 0.84 BMP1 (0.44) FOLH1BACE1CTSDDPP8DPP9
SCHEMBL2195713 0.84 DPP4 (0.43) BACE1CTSDDPP8DPP9DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190070251-A1 POLYMER CONJUGATES OF THERAPEUTIC PEPTIDES NEKTAR THERAPEUTICS 2019-03-07 US disclosed
US-9682153-B2 Polymer conjugates of therapeutic peptides NEKTAR THERAPEUTICS (US) 2017-06-20 US disclosed
US-20160022828-A1 POLYMER CONJUGATES OF THERAPEUTIC PEPTIDES NEKTAR THERAPEUTICS 2016-01-28 US disclosed
US-9173951-B2 Carbohydrate-based drug delivery polymers and conjugates thereof NEKTAR THERAPEUTICS (US) 2015-11-03 US disclosed
US-20150051371-A1 CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF NEKTAR THERAPEUTICS (US) 2015-02-19 US disclosed
US-20110171312-A1 MODIFIED THERAPEUTIC PEPTIDES, METHODS OF THEIR PREPARATION AND USE NEKTAR THERAPEUTICS (US) 2011-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160022828-A1 POLYMER CONJUGATES OF THERAPEUTIC PEPTIDES NGLY1, CD44, IAPP FOLH1 64/4885BACE1 2543/4885CTSD 1192/4885
US-20150051371-A1 CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF STT3B, STT3A, DDOST FOLH1 287/4885BACE1 3429/4885CTSD 1143/4885
US-20190070251-A1 POLYMER CONJUGATES OF THERAPEUTIC PEPTIDES NGLY1, CD44, IAPP FOLH1 64/4885BACE1 2543/4885CTSD 1192/4885
US-20110171312-A1 MODIFIED THERAPEUTIC PEPTIDES, METHODS OF THEIR PREPARATION AND USE DNPEP, VIP, PTMS FOLH1 31/4885BACE1 1932/4885CTSD 912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.